Coronary thrombo-embolic events after Covid-19 vaccination- a single centre study

Showkathali, Refai; Yalamanchi, Radhapriya; Narra, Lavanya; Vinayagamoorthy, Nandhini; Gunasekaran, Sengottuvelu; Nayak, Rajeshwari; Reddy, Y. Vijayachandra; Mahilmaran, Asha, Srinivasan, Kanthallu Narayanamoorthy; Oomman, Abraham; Kaliyamoorthy, Dhamodaran.
Indian Heart J ; 2022 Apr; 74(2): 131-134
Artículo | IMSEAR | ID: sea-220882

Documentos relacionados

  1. Coronary thrombo-embolic events after Covid-19 vaccination- a single centre study.
  2. Postmortem PF4 antibodies confirm a rare case of thrombosis thrombocytopenia syndrome associated with ChAdOx1 nCoV-19 anti-COVID vaccination.
  3. Longitudinally extensive transverse myelitis following ChAdOx1 nCoV-19 vaccine.
  4. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
  5. Thrombus Distribution in Vaccine-induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
  6. DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors.
  7. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
  8. Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report.
  9. Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity.
  10. Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.